| 000 | 01489 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513191523.0 | ||
| 264 | 0 | _c19991104 | |
| 008 | 199911s 0 0 eng d | ||
| 022 | _a0938-7994 | ||
| 024 | 7 |
_a10.1007/s003300050849 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDoerfler, A | |
| 245 | 0 | 0 |
_aIodixanol in cerebral computed tomography: a randomized, double-blind, phase-III, parallel study with iodixanol and iohexol. _h[electronic resource] |
| 260 |
_bEuropean radiology _c1999 |
||
| 300 |
_a1362-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBrain _xdiagnostic imaging |
| 650 | 0 | 4 |
_aContrast Media _xadverse effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIohexol _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 |
_aTriiodobenzoic Acids _xadverse effects |
| 700 | 1 | _aFiebach, J | |
| 700 | 1 | _aWanke, I | |
| 700 | 1 | _aForsting, M | |
| 700 | 1 | _aHenseke, P | |
| 700 | 1 | _aSartor, K | |
| 773 | 0 |
_tEuropean radiology _gvol. 9 _gno. 7 _gp. 1362-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s003300050849 _zAvailable from publisher's website |
| 999 |
_c10417978 _d10417978 |
||